JLE

MT Cardio

MT Cardio

Volume 2, issue 2, Mars-Avril 2006

MENU

Volume 2, issue 2, Mars-Avril 2006

Éditorial

En accès libre Après FIELD, les fibrates peuvent-ils être utilisés en prévention cardiovasculaire ? (p.149-53)
Michel Farnier
Free Access

Dossier – Syndrome métabolique

En accès libre Metabolic syndrome and physiopathology of insulin resistance. (p.155-64)
Jacqueline Capeau, Jean-Philippe Bastard, Corinne Vigouroux
Free Access

En accès libre Therapeutic management of the metabolic syndrome (p.165-73)
Frédéric Illouz, Philippe Fressinaud, Pierre-Henri Ducluzeau
Free Access

En accès libre Metabolic syndrome: definition and epidemiology (p.174-82)
François Raoux
Free Access

Actus

En accès libre Sommaire (p.183)

Free Access

En accès libre Efficacy of transesophageal echocardiography-guided cardioversion of patients with atrial fibrillation at 6 months: a randomized controlled trial. (p.184-5)
Stéphane Ederhy
Free Access

En accès libre Prediction of the recurrence of atrial fibrillation after cardioversion in the Atrial Fibrillation followupinvestigation of rhythm management (AFFIRM) study. (p.186-7)
Stéphane Ederhy
Free Access

En accès libre Enhanced sensitivity of dobutamine stress echocardiography by observing wall motion abnormalities during the recovery phase after acute beta-blocker administration. (p.188-9)
Sandra Janower
Free Access

En accès libre Impact of prosthesis-patient mismatch on cardiac events and midterm mortality after aortic valve replacement in patients with pure aortic stenosis. (p.190-1)
Sandra Janower
Free Access

En accès libre Left ventricular apical ballooning due to severe physical stress in patients admitted to the medical ICU (p.192-3)
Sandra Janower
Free Access

En accès libre Reduction in ventricular tachyarrhythmias with statins in the multicenter automatic defibrillator implantation trial (MADIT)-II. (p.194-5)
Catherine Meuleman
Free Access

En accès libre The effect of valsartan, captopril or both on atherosclerotic events after acute myocardial infarction: an analysis of the valsartan in acute myocardial infarction trial (VALIANT). (p.196-8)
Catherine Meuleman
Free Access

En accès libre Long-term outcome of surgically treated aortic regurgitation. Influence of guideline adherence toward early surgery. (p.199-200)
Catherine Meuleman
Free Access

En accès libre Analysis of regional left ventricular function by cineventriculography, cardiac magnetic resonnance imaging and unenhanced and contrast-enhanced echocardiography. (p.201-2)
Olivier Milleron
Free Access

En accès libre International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis. (p.203-5)
François Raoux
Free Access

En accès libre The Admiral Investigators. Three-year duration of benefit from abciximab in patients receiving stents for acute myocardial infarction in the randomized double-blind ADMIRAL study. (p.206-7)
Karim Wahbi
Free Access

Revues

En accès libre Cardiac amyloidosis (p.208-14)
Gilles Grateau
Free Access

En accès libre Effects of exercise training on left ventricular dysfunction. (p.215-22)
Marie-Christine Iliou
Free Access

En accès libre Myocardial scan and prognosis in coronary disease. (p.223-34)
Maurice Lévy
Free Access

En accès libre Treatment of obstructive cardiomyopathy by septal alcoholic ablation: which indications? (p.235-47)
Marie-Christine Malergue
Free Access

En accès libre Measurement of left ventricular mass: echocardiography and/or MRI? (p.249-54)
Nicolas Mansencal, Alban Redheuil
Free Access

En accès libre Ischemic mitral regurgitation: from physiology to treatment. (p.255-67)
Emmanuel Messas
Free Access